// App-Quantinova.ai

8586 : Cyclophosphamide, bortezomib, and dexamethasone (CYBORD) treatment for relapsed/refractory multiple myeloma.

Researchers

Presenter

  • Jorge Monge

Principal Investigators

  • K. Martin Kortm

  • Craig B. Reeder

  • Angela Mayo

  • Rafael Fonseca

  • A. Keith Stewart

  • P. Leif Bergsagel

  • Joseph Mikhael

Medical Centers

  • Mayo Clinic, Scottsdale, AZ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Peripheral neuropathy

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Bortezomib

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved